Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)

NCT02344225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Retinopathy of Prematurity

Interventions

DRUG: Caffeine citrate
DRUG: Ibuprofen
DRUG: Ketorolac

Sponsor

State University of New York - Downstate Medical Center

Collaborators

[object Object]
[object Object]